Cable Hill Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Cable Hill Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-14	Closed	-$1K	–	796
2015 Q2	$1K	Hold	14	–	–	﹤0.01%	721
2015 Q1	$0	Hold	14	–	–	﹤0.01%	773
2014 Q4	$0	Buy	+14	New	+$10	﹤0.01%	718

Other funds holding GCVRZ

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Cable Hill Partners's GCVRZ Position: Q3 2015 in Review

Cable Hill Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2015, closing a stake of 14 shares — an estimated $1K sold.

Cable Hill Partners first reported a position in GCVRZ in Q4 2014 and held it in 3 quarters. The position peaked at $1K in Q2 2015. 117 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2015.

Cable Hill Partners reported no remaining Sanofi Contingent Value Rights position as of Q3 2015 after selling out during the quarter.
Cable Hill Partners sold 14 Sanofi Contingent Value Rights shares in Q3 2015, an estimated $1K.
Cable Hill Partners first reported a position in Sanofi Contingent Value Rights in Q4 2014 and held it in 3 quarters.
Cable Hill Partners's Sanofi Contingent Value Rights position peaked at $1K in Q2 2015.
117 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2015.

Based on Cable Hill Partners's 13F filing for Q3 2015, filed 4 Aug 2016.